BeyondSpring Inc. (BYSI) stock

BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.60−0.04 (-6.65%)

Close on Nov 12, 2026Market cap $24.71MP/E –Yield –

BeyondSpring ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

BeyondSpring has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in BeyondSpring's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BYSI.

Advertisement
300 × 250

See a number that looks wrong?